SS

Siddharth Suryakant Deshmukh

Active Director Director DIN 11026036
DIN 11026036 First appointment Mar 2025 Primary industry Wood
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Siddharth Suryakant Deshmukh

Data last updated:

Siddharth Suryakant Deshmukh is a Director at Synovia Pharmachem Private Limited (since 2025). The company operates in Wood.

DIN 11026036
Primary Designation Director
Industry Wood
First Appointment 28 Mar 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Synovia Pharmachem Private Limited U20119GJ2025PTC160798
Director28 Mar 20252025Active

Board colleagues of Siddharth Suryakant Deshmukh

NameDINCompanyDesignation
Suryakant Deshmukh11026037Synovia Pharmachem Private LimitedDirector

Directorship timeline

Open interactive timeline →
Synovia Pharmachem Private Limited
Premium access

Shareholding and investment profile for Siddharth Suryakant Deshmukh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Siddharth Suryakant Deshmukh

Siddharth Suryakant Deshmukh currently holds 1 directorship: Synovia Pharmachem Private Limited (Director, since 28 Mar 2025).

Siddharth Suryakant Deshmukh was first appointed on 28 Mar 2025 as Director at Synovia Pharmachem Private Limited.

The current boards of Siddharth Suryakant Deshmukh's companies include Suryakant Deshmukh (Synovia Pharmachem Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available